Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma
Open Access
- 1 November 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (11), 1927-1936
- https://doi.org/10.1038/mt.2010.183
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN productionProceedings of the National Academy of Sciences of the United States of America, 2010
- Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus VectorsCancer Research, 2009
- Phase Ib Trial of Oncolytic Herpes Virus G207 Shows Safety of Multiple Injections and Documents Viral ReplicationMolecular Therapy, 2009
- Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBMMolecular Therapy, 2009
- The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human GliomasClinical Cancer Research, 2008
- Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin ReceptorPLoS Biology, 2008
- Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent GliomasHuman Gene Therapy, 2008
- Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With CyclophosphamideMolecular Therapy, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSFMolecular Therapy, 2006